XARACOLL® (bupivacaine HCl) implant

XARACOLL

The first and only implant to deliver local, long-lasting, postsurgical analgesia for up to 24 hours following OPEN INGUINAL HERNIA REPAIR in adults

See the science

A targeted approach to postsurgical pain relief

See the science
See how to place

Simple implant placement into surgical site

See how to place
See the results

Long-lasting pain relief; use of opioids reduced

See the results
IMPORTANT SAFETY INFORMATION

ADVERSE REACTIONS

  • Most common adverse reactions in clinical trials (incidence ≥2% and higher than placebo) included incision site swelling, dysgeusia, headache, tremor, blurred vision, seroma, scrotal swelling, pyrexia, oral hypoaesthesia, and post procedural discharge.